LGALS3 and cancer: In addition to MHC-II, other LAG3 ligands have been discovered: galectine 3 (Gal-3), fibrinogen-like protein 1 (FLG-1), and its overexpression on cancer cells have been identified as a mechanism of tumor immune evasion (13, 14).